Natalie McNamee

Natalie McNamee

Inversor de Capital Privado en
Tarnagulla Ventures Pty Ltd.
.
Consumer Services
Health Technology
Finance

Perfil

Natalie has been a Director of Tarnagulla Ventures Pty Ltd since 2015.
She had led the investment diligence into most of the portfolio companies since then, including Lubris BioPharma, a company which has since successfully licensed their lead indication to Novartis.
Prior to returning to Australia, Natalie worked for Tocagen Inc, a gene therapy company, based in San Diego, in their business development team whilst finishing her Masters.
She then worked as a bioengineer at the then-newly formed Quanticel Pharmaceuticals, a cancer stem cell focused drug developer.
Quanticel was acquired by Celgene for $485M in 2015.
Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.

Cargos activos de Natalie McNamee

EmpresasCargoInicio
Inversor de Capital Privado 01/01/2015

Antiguos cargos conocidos de Natalie McNamee.

Formación de Natalie McNamee.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

1

Relaciones de 1er grado

4

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas4

Consumer Services

Consumer Services

Health Technology

Finance